(Q33361776)

English

A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell (English)
Nandita Bhattacharya

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit